Finnish Institute for Health and Welfare (THL), Finland. (2022). The coronavirus epidemic is still on the decline in Finland – vaccinations reduce the incidence of severe disease in particular - Press release - THL. Finnish Institute for Health and Welfare (THL), Finland.
PAHO. (2022). As COVID-19 cases continue to rise in the Americas, many are at risk of developing post-COVID condition - PAHO/WHO | Pan American Health Organization.
Jul 01, M. V. B. | N. W. | C. N. |, & 2022. (222 C.E.). COVID vaccines prevented poor outcomes in people of all sizes. CIDRAP.
Koyama, A. K., Koumans, E. H., Sircar, K., Lavery, A. M., Ko, J. Y., Hsu, J., Anderson, K. N., & Siegel, D. A. (2022). Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States.
Lacek, K. A., Rambo-Martin, B. L., Batra, D., Zheng, X., Hassell, N., Sakaguchi, H., Peacock, T., Groves, N., Keller, M., Wilson, M. M., Sheth, M., Davis, M. L., Borroughs, M., Gerhart, J., Shepard, S. S., Cook, P. W., Lee, J., Wentworth, D. E., Barnes, J. R., … Paden, C. R. (2022). SARS-CoV-2 Delta–Omicron Recombinant Viruses, United States.
Hogarth, F., Coffey, P., Goddard, L., Lewis, S., Labib, S., Wilmot, M., Andersson, P., Sherry, N., Seemann, T., Howden, B. P., Freeman, K., Baird, R., Hosegood, I., McDermott, K., Walsh, N., Polkinghorne, B., Marshall, C., Davies, J., Krause, V., & Meumann, E. M. (2022). Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021.
Sofonea, M. T., Roquebert, B., Foulongne, V., Morquin, D., Verdurme, L., Trombert-Paolantoni, S., Roussel, M., Bonetti, J.-C., Zerah, J., Haim-Boukobza, S., & Alizon, S. (2022). Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022.
Nevejan, L., Cuypers, L., Laenen, L., Loo, L. V., Vermeulen, F., Wollants, E., Hecke, I. V., Desmet, S., Lagrou, K., Maes, P., & André, E. (2022). Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
Kremer, C., Braeye, T., Proesmans, K., Emmanuel André, Torneri, A., & Hens, N. (2022). Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021.
Matsumura, Y., Nagao, M., Yamamoto, M., Tsuchido, Y., Noguchi, T., Shinohara, K., Yukawa, S., Inoue, H., & Ikeda, T. (2022). Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020–June 2021.
Magro, M., Parriott, A., Mitsunaga, T., & Epson, E. (2022). Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
Care, A. G. D. of H. and A. (2022). Oral Treatments for COVID-19 (Part 1). Australian Government Department of Health and Aged Care.
Care, A. G. D. of H. and A. (2022). Oral Treatments for COVID-19 (Part 2). Australian Government Department of Health and Aged Care.
Ganesh, A., Reis, I. R., Varma, M., Patry, D. G., & Cooke, L. J. (2022). Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis. Canadian Journal of Neurological Sciences, 49(4), 514–531.
Gemmill, A., Casey, J. A., Catalano, R., Karasek, D., Margerison, C. E., & Bruckner, T. (2022). Changes in preterm birth and caesarean deliveries in the United States during the SARS-CoV-2 pandemic. Paediatric and Perinatal Epidemiology, 36(4), 485–489.
de Moura, P. T., Rockenbach, C. A., Mendes, C. da R., Mendes, G. U., Ghiggi, L. A., Diel, M., Martini, P., Camozzato Filho, P., de Castro, R. S. B., Mello de Mello, R., Kovalski, R., Mendes Filho, V. A., & Mosqueiro, B. P. (2022). Depression and suicide risk during the Covid-19 pandemic at a Brazilian public health psychosocial addiction care center: a preliminary report. Trends in Psychiatry and Psychotherapy, 44.
Regan, A. K., Arah, O. A., & Sullivan, S. G. (2022). Performance of diagnostic coding and laboratory testing results to measure COVID-19 during pregnancy and associations with pregnancy outcomes. Paediatric and Perinatal Epidemiology, 36(4), 508–517.
Patel, H., Hassell, A., Cyriacks, B., Fisher, B., Tonelli, W., & Davis, C. (2022). Building a Real-Time Remote Patient Monitoring Patient Safety Program for COVID-19 Patients. American Journal of Medical Quality, 37(4), 342–347., Z. S.-. (2022). COVID-19 : l’Île maintient des mesures sanitaires pour deux semaines | Coronavirus.
Olsen, E. O., Roth, N. M., Aveni, K., Santos, P., Sizemore, L., Halai, U.-A., Nestoridi, E., Barton, J. E., Mobley, E., Siebman, S., Fussman, C., Mbotha, D., Dzimira, P., Silcox, K. M., Khuwaja, S., Roscom, D., Lush, M., Chicchelly, S., Delgado-López, C., … Woodworth, K. R. (2022). SARS-CoV-2 infections among neonates born to pregnant people with SARS-CoV-2 infection: Maternal, pregnancy and birth characteristics. Paediatric and Perinatal Epidemiology, 36(4), 476–484.
Simon, V., Kota, V., Bloomquist, R. F., Hanley, H. B., Forgacs, D., Pahwa, S., Pallikkuth, S., Miller, L. G., Schaenman, J., Yeaman, M. R., Manthei, D., Wolf, J., Gaur, A. H., Estepp, J. H., Srivastava, K., Carreño, J. M., Cuevas, F., PARIS/SPARTA Study Group, Ellebedy, A. H., … Krammer, F. (2022). PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2. MSphere, 7(3).
Lopez, C. A., Cunningham, C. H., Pugh, S., Brandt, K., Vanna, U. P., Delacruz, M. J., Guerra, Q., Bhowmik, D. R., Goldstein, S. J., Hou, Y. J., Gearhart, M., Wiethorn, C., Pope, C., Amditis, C., Pruitt, K., Newberry-Dillon, C., Schmitz, J. L., Premkumar, L., Adimora, A. A., … Markmann, A. J. (2022). Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020. MSphere, 7(3), e00841-21.
Klinger, I., Heckel, M., Shahda, S., Kriesen, U., Schneider, C., Kurkowski, S., Junghanss, C., & Ostgathe, C. (2022). COVID-19: Challenges and solutions for the provision of care to seriously ill and dying people and their relatives during SARS-CoV-2 pandemic – perspectives of pandemic response team members: A qualitative study on the basis of expert interviews (part of PallPan). Palliative Medicine, 36(7), 1092–1103.
Lee, K., & Cha, H. (2022). Predictors of Adherence to COVID-19 Preventive Measures in South Korea Based on the Health Belief Model: A Cross-Sectional Study. Asia Pacific Journal of Public Health, 34(5), 569–572.
Protection against SARS-CoV-2 after Vaccination and Previous Infection. (2022). New England Journal of Medicine, 386(26), 2534–2535.
Mombelli, J. M. R., Barbosa, G. C., Claro, H. G., Boska, G. de A., & Oliveira, M. A. F. de. (2022). Predictors burden in mental health workers during the COVID-19 pandemic. Revista Brasileira de Enfermagem, 75.
Layton, B. A., Kaya, D., Kelly, C., Williamson, K. J., Alegre, D., Bachhuber, S. M., Banwarth, P. G., Bethel, J. W., Carter, K., Dalziel, B. D., Dasenko, M., Geniza, M., George, A., Girard, A.-M., Haggerty, R., Higley, K. A., Hynes, D. M., Lubchenco, J., McLaughlin, K. R., … Radniecki, T. S. (2022). Evaluation of a Wastewater-Based Epidemiological Approach to Estimate the Prevalence of SARS-CoV-2 Infections and the Detection of Viral Variants in Disparate Oregon Communities at City and Neighborhood Scales. Environmental Health Perspectives, 130(6).
Duncan, N. A., L’Her, G. F., Osborne, A. G., Sawyer, S. L., & Deinert, M. R. (2022). Estimating the effect of non-pharmaceutical interventions on US SARS-CoV-2 infections in the first year of the pandemic. Royal Society Open Science, 9(6), 210875.
Bandyopadhyay, A., Schips, M., Mitra, T., Khailaie, S., Binder, S. C., & Meyer-Hermann, M. (2022). Testing and isolation to prevent overloaded healthcare facilities and reduce death rates in the SARS-CoV-2 pandemic in Italy. Communications Medicine, 2(1), 1–16.
Leng, T., Hill, E. M., Keeling, M. J., Tildesley, M. J., & Thompson, R. N. (2022). The effect of notification window length on the epidemiological impact of COVID-19 contact tracing mobile applications. Communications Medicine, 2, 74.
Louw, A. S., Fu, J., Raut, A., Zulhilmi, A., Yao, S., McAlinn, M., Fujikawa, A., Siddique, M. T., Wang, X., Yu, X., Mandvikar, K., & Avtar, R. (2022). The role of remote sensing during a global disaster: COVID-19 pandemic as case study. Remote Sensing Applications: Society and Environment, 27, 100789.
Cuadros, D. F., Moreno, C. M., Musuka, G., Miller, F. D., Coule, P., & MacKinnon, N. J. (2022). Association Between Vaccination Coverage Disparity and the Dynamics of the COVID-19 Delta and Omicron Waves in the US. Frontiers in Medicine, 9, 898101.
Parums, D. V. (2022). World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2. Medical Science Monitor, 28.
Bagaria, J., Jansen, T., Marques, D. F., Hooiveld, M., McMenamin, J., Lusignan, S. de, Vilcu, A.-M., Meijer, A., Rodrigues, A.-P., Brytting, M., Mazagatos, C., Cogdale, J., Werf, S. van der, Dijkstra, F., Guiomar, R., Enkirch, T., Valenciano, M., & Team, I.-M.-C.-19 study. (2022). Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned. Eurosurveillance, 27(26).
Samson, M. E. (2022). Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting – District of Columbia, January 2022 | Clinical Infectious Diseases | Oxford Academic.
Belan, M., Charmet, T., Schaeffer, L., Tubiana, S., Duval, X., Lucet, J.-C., Fontanet, A., Birgand, G., & Kernéis, S. (2022). SARS-CoV-2 Exposures of Healthcare Workers from Primary Care, Long-Term Care Facilities and Hospitals: A Nationwide Matched Case-Control Study. Clinical Microbiology and Infection.
Mutubuki, E. N., van der Maaden, T., Leung, K., Wong, A., Tulen, A. D., de Bruijn, S., Haverman, L., Knoop, H., Franz, E., van Hoek, A. J., & van den Wijngaard, C. C. (2022). Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study) | BMJ Open.
Stufano, A., Lucchese, G., Stahl, B., Grattagliano, I., Dassisti, L., Lovreglio, P., Flöel, A., & Iavicoli, I. (2022). Impact of COVID-19 emergency on the psychological well-being of susceptible individuals. Scientific Reports, 12(1).
Darques, R., Trottier, J., Gaudin, R., & Ait-Mouheb, N. (2022). Clustering and mapping the first COVID-19 outbreak in France. BMC Public Health, 22(1), 1279.
Ghassemi, A. E. (2022). Reliable and comprehensive assessment of post-traumatic stress disorder is required to provide population-based prevention and treatment of PTSD during the COVID-19 pandemic. Evidence-Based Nursing, 25(3), 102–102.
Tapia-Muñoz, T., González-Santa Cruz, A., Clarke, H., Morris, W., Palmeiro-Silva, Y., & Allel, K. (2022). COVID-19 attributed mortality and ambient temperature: a global ecological study using a two-stage regression model. Pathogens and Global Health, 116(5), 319–329.
Chivese, T., Matizanadzo, J. T., Musa, O. A. H., Hindy, G., Furuya-Kanamori, L., Islam, N., Al-Shebly, R., Shalaby, R., Habibullah, M., Al-Marwani, T. A., Hourani, R. F., Nawaz, A. D., Haider, M. Z., Emara, M. M., Cyprian, F., & Doi, S. A. R. (2022). The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. Pathogens and Global Health, 116(5), 269–281.
Salazar, T. L., Pollard, D. L., Pina-Thomas, D. M., & Benton, M. J. (2022). Parental vaccine hesitancy and concerns regarding the COVID-19 virus. Journal of Pediatric Nursing, 65, 10–15.
Montalbán, A., Corder, R. M., & Gomes, M. G. M. (2022). Herd immunity under individual variation and reinfection. Journal of Mathematical Biology, 85(1), 2.
Rider, L. G., Parks, C. G., Wilkerson, J., Schiffenbauer, A. I., Kwok, R. K., Noroozi Farhadi, P., Nazir, S., Ritter, R., Sirotich, E., Kennedy, K., Larche, M. J., Levine, M., Sattui, S. E., Liew, J. W., Harrison, C. O., Moni, T. T., Miller, A. K., Putman, M., Hausmann, J., … the COVID-19 Global Rheumatology Alliance Vaccine Survey Group. (2022). Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology, 61(SI2), SI143–SI150.
Gallagher, T. (2022). Many Keys Unlock the Doors for Virus Entry. MBio, 13(3), e00445-22.
O’Shea, M., Mou, L., Xu, L., & Aikins, R. (2022). Communicating COVID-19: Analyzing Higher Education Institutional Responses in Canada, China, and the USA. Higher Education Policy.
Kreski, N. T., Keyes, K. M., Parks, M. J., & Patrick, M. E. (2022). Depressive and anxious symptoms among young adults in the COVID-19 pandemic: Results from monitoring the future. Depression and Anxiety, 39(6), 536–547.
Callaway, E. (2022). What Omicron’s BA.4 and BA.5 variants mean for the pandemic. Nature, 606(7916), 848–849.
Laestadius, L. I., Guidry, J. P. D., Bishop, A., & Campos-Castillo, C. (2022). State Health Department Communication about Long COVID in the United States on Facebook: Risks, Prevention, and Support. International Journal of Environmental Research and Public Health, 19(10), 5973.